Showing 2511-2520 of 18620 results for "".
Acne, Eczema, and Psoriasis: Improving Treatment Adherence in Younger Patients
https://reachmd.com/programs/dermconsult/acne-eczema-and-psoriasis-improving-treatment-adherence-in-younger-patients/35502/When treating adolescents and young adults with acne, eczema, and psoriasis, getting them to adhere to their regimen may be difficult. However, practical strategies like explaining the therapy and its side effects and encouraging patients to set reminders can help them stay on track and optimize theFDA Grants Interchangeability to HADLIMA
https://practicaldermatology.com/series/dermwire-tv/fda-grants-interchangeability-to-hadlima/35962/In this week's DermwireTV, the FDA grants full interchangeability to HADLIMA; new research shows the impact of UV exposure on global skin cancer cases; and coverage from Music City SCALE addresses barriers to patient access to new therapies.How Diagnostic Delays in gMG Impact Disease Severity, Outcomes, and Quality of Life
https://reachmd.com/programs/neurofrontiers/how-diagnostic-delays-in-gmg-impact-disease-severity-outcomes-and-quality-of-life/35492/The symptom variability, prolonged asymptomatic periods, and inconsistent presentations of generalized myasthenia gravis (gMG) often lead to significant diagnostic delays and misdiagnoses. Based on recent studies, these delays then correlate with increased disease severity, longer time to symptom coPredicting Immunotherapy Outcomes in Head and Neck Cancer: The Role of Genetic Signatures
https://reachmd.com/programs/project-oncology/predicting-immunotherapy-outcomes-in-head-and-neck-cancer-the-role-of-genetic-signatures/32998/Head and neck squamous cell carcinoma presents significant treatment challenges, like high mortality rates and limited predictive tools for immunotherapy success. That’s why a recent study examined genetic signatures that may help identify which patients will benefit from immunotherapy. To learn aboStratifying ICI-P Risk in Non-Small Cell Lung Cancer with Genetic and Radiographic Markers
https://reachmd.com/programs/project-oncology/stratifying-ici-p-risk-in-non-small-cell-lung-cancer-with-genetic-and-radiographic-markers/35659/New data from MD Anderson highlights a promising approach to predicting ICI-associated pneumonitis (ICI-P) in patients with NSCLC. Learn about how the findings could help personalize ICI therapy, reduce adverse outcomes, and improve clinical decision-making for at-risk patients. This research was prThe Subtle Threats of Benzene on Airway Health: Insights from an In Vitro ALI Model
https://reachmd.com/programs/clinicians-roundtable/the-subtle-threats-of-benzene-on-airway-health-insights-from-an-in-vitro-ali-model/35658/A recent study published in the American Journal of Respiratory and Critical Care Medicine found that sub-cytotoxic benzene exposure can disrupt oxidative stress signaling and immune cell chemotaxis in airway epithelial cells without activating typical inflammatory of metabolic pathways. Read aboutNail Disease and JAK Inhibitor Safety
https://reachmd.com/programs/practical-dermatology/nail-disease-and-jak-inhibitor-safety/35897/Brad Glick, DO, talks about the basics of nail anatomy, physiology, disease presentation, and treatments, as well as the safety of JAK inhibitors, at Music City SCALE 2025.Quality-of-Life Challenges in gMG Care: Navigating the Invisible Burden
https://reachmd.com/programs/neurofrontiers/quality-of-life-challenges-in-gmg-care-navigating-the-invisible-burden/35493/Generalized myasthenia gravis (gMG) presents with highly variable symptoms that can significantly impact a patient’s quality of life, often in ways that are invisible to others. That’s why Dr. Maxwell Levy joins us to discuss these unmet needs and how we can address them with various clinical strateMATV NEWS: Genesis: Innovations in Aesthetic Regenerative Medicine Registration Opens And More
https://reachmd.com/programs/modern-aesthetics/MATV-NEWS-Genesis-Innovations-Aesthetic-Regenerative-Medicine-Registration-Opens-More/33233/In this week's episode of MATV News, an update on the 2025 Genesis: Innovations in Aesthetic Regenerative Medicine Meeting; the FDA approves a new neurotoxin for the glabellar lines; Closing the health care gender gap; and Martha Stewart was the keynote speaker for 2025 AAD Annual Meeting.The Role of Augmented Intelligence in Electrodiagnostic and Neuromuscular Medicine
https://reachmd.com/programs/neurofrontiers/the-role-of-augmented-intelligence-in-electrodiagnostic-and-neuromuscular-medicine/26393/Tune in to learn about the current and future applications of augmented intelligence in neuromuscular and electrodiagnostic medicine.